Gonadotropin-releasing hormone agonist versus expectant management for treating multiple leiomyomas after myomectomy: the study protocol for a multicentre, prospective, randomised controlled clinical trial

INTRODUCTION: Leiomyoma recurrence is a major concern for long-term myomectomy management, especially for multiple leiomyomas. Gonadotropin-releasing hormone agonist (GnRHa) is one of the most effective medications to reduce the volume of fibroids and the uterus. However, its role in preventing recu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jia, Ma, Xiangyi, Wang, Wenwen, Zhang, Minli, Yu, Zhiying, Zhang, Wei, Hong, Li, Li, Zhiying, Li, Lin, Du, Xin, Feng, Yun, Guo, Ruixia, Zhang, Chunlian, Yue, Qingfen, Wang, Wuliang, Wang, Shixuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524271/
https://www.ncbi.nlm.nih.gov/pubmed/34663648
http://dx.doi.org/10.1136/bmjopen-2020-044347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524271/
https://www.ncbi.nlm.nih.gov/pubmed/34663648
http://dx.doi.org/10.1136/bmjopen-2020-044347

Ejemplares similares